Literature DB >> 10197393

Pathophysiology of pleural space infections.

V B Antony1, K A Mohammed.   

Abstract

The pleura responds to the presence of infecting organisms with a vigorous inflammatory response associated with an exudation of white blood cells and proteins. Changes in pleural permeability lead to formation of an exudative pleural effusion. The pleural mesothelial cell is the primary cell lining the pleural space and, when activated by the presence of organisms, initiates the inflammatory response by releasing a battery of chemokines and cytokines. Mesothelial cells are actively phagocytic and also release oxidants and proteases. The acute inflammatory process may resolve with appropriate antibiotic therapy and drainage leaving minimal fibrosis. However, under certain circumstances vigorous pleural fibrosis with scarring and loss of delineation of pleural surfaces can occur. Recognition of the stage of development of the empyema is an important clinical judgement that can affect outcome. The pathogenesis of infections of the pleural space and the role played by the various cell types is delineated in this article.

Entities:  

Mesh:

Year:  1999        PMID: 10197393

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  7 in total

1.  Moxifloxacin pharmacokinetics and pleural fluid penetration in patients with pleural effusion.

Authors:  Kalliopi Chatzika; Katerina Manika; Paschalina Kontou; Georgia Pitsiou; Despina Papakosta; Konstantinos Zarogoulidis; Ioannis Kioumis
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

2.  Angiogenic factors and angiogenesis inhibitors in exudative pleural effusions.

Authors:  Eva Ruiz; Carmen Alemán; José Alegre; Jasone Monasterio; Rosa Ma Segura; Lluis Armadans; Ana Vázquez; Teresa Soriano; Tomás Fernández de Sevilla
Journal:  Lung       Date:  2005 May-Jun       Impact factor: 2.584

3.  Profile of Metalloproteinases and Their Association with Inflammatory Markers in Pleural Effusions.

Authors:  Lisete Ribeiro Teixeira; Murilo B Dias; Roberta K B Sales; Leila Antonangelo; Vanessa A Alvarenga; Juliana Puka; Evaldo Marchi; Milena Marques Pagliarelli Acencio
Journal:  Lung       Date:  2016-09-27       Impact factor: 2.584

4.  Morphological analysis of leucocyte transmigration in the pleural cavity.

Authors:  R Teng; K Johkura; N Ogiwara; X Zhao; L Cui; I Iida; Y Okouchi; K Asanuma; K Sasaki
Journal:  J Anat       Date:  2003-10       Impact factor: 2.610

5.  Management of pleural empyema in a 12-year-old obese patient with COVID-19: a pediatric case report.

Authors:  Reza Abbasi; Farnaz Sadat Javanmardi; Ahmad Mokhtari; Parisa Hosseinpour; Reza Shahriarirad; Kamyar Ebrahimi
Journal:  BMC Pediatr       Date:  2021-11-30       Impact factor: 2.125

Review 6.  Update on Novel Targeted Therapy for Pleural Organization and Fibrosis.

Authors:  Torry A Tucker; Steven Idell
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

7.  Transmembrane Tumor Necrosis Factor Controls Myeloid-Derived Suppressor Cell Activity via TNF Receptor 2 and Protects from Excessive Inflammation during BCG-Induced Pleurisy.

Authors:  Leslie Chavez-Galan; Dominique Vesin; Husnu Uysal; Guillaume Blaser; Mahdia Benkhoucha; Bernhard Ryffel; Valérie F J Quesniaux; Irene Garcia
Journal:  Front Immunol       Date:  2017-08-25       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.